What it's actually good for
Fadogia agrestis is a shrub from the Rubiaceae family, native to Nigeria and used in West African folk medicine as an aphrodisiac. It became a supplement-shelf staple after high-profile podcast mentions turned it into a shorthand for "natural testosterone booster." The gap between that reputation and the evidence is about as wide as it gets on this site: zero published human clinical trials. Not a small one, not a poorly controlled one — none. Everything sold under this name is extrapolated from two rat studies out of a single Nigerian research group, run twenty years ago.
What the research says
Testosterone and mating behavior (Grade C). The whole "boosts testosterone" claim traces back to Yakubu et al. (2005), published in Asian Journal of Andrology. Male rats dosed at 18-100 mg/kg for five days showed dose-dependent increases in serum testosterone alongside more mounting and intromission behavior — a rat proxy for libido. That's a real finding, but it's a five-day study in a handful of rodents, using a route, dose, and extract preparation that has never been reproduced in humans or replicated independently by another lab. Rat testosterone pharmacology does not reliably predict human response, and no one has measured what this extract does to a person's hormone panel.
Testicular toxicity (also from the source studies). The same research group followed up in 2008 with a 28-day dosing study and found the extract altered testicular cholesterol, protein, and enzyme markers in a dose-dependent way — mild and reversible at the lowest dose (18 mg/kg), but irreversible histological damage at 50 and 100 mg/kg. In other words, the same compound and research program that produced the "testosterone boost" headline also produced a testicular toxicity signal, in the same animal model, at doses in the range people actually take. That combination — one small evidence base supporting both the benefit claim and a harm signal, with no human safety data to separate the two — is why this earns a C rather than an unproven-but-probably-fine rating.
How much, and which form
Commercial capsules commonly list 300-600 mg/day of stem extract, but this dose was not derived from any human trial — it's a marketing convention, not a validated protocol. There's no standardized extraction method across brands, no established human pharmacokinetics, and limited oversight of what's actually in the capsule given the supply chain (wild-harvested stem from Nigeria, processed for a Western supplement market with little independent verification of species identity or extract concentration).
Safety & interactions
Human safety data does not exist. The only toxicity signal on record is the dose-dependent testicular histological damage in rats described above, and there is no way to know whether or how that maps onto the doses in a typical capsule. There are no formal drug interaction studies; anyone on hormone therapy or medication affecting the reproductive axis should treat this as an unknown, not a null risk. This is informational only, not medical advice — talk to a clinician before starting, especially if pregnant, nursing, on medication, or managing a chronic condition.
How we picked the brand
Given the total absence of human trials and standardization, brand selection here comes down to basic supply-chain hygiene rather than efficacy: third-party testing for identity and contamination, transparent labeling, and no proprietary blends hiding the actual dose. That bar filters out the worst of the market — it does not make the underlying compound proven.